Peptides exhibit lower affinity and a shorter half-life in the body than antibodies. Conversely,
peptides demonstrate higher efficiency in tissue penetration and cell internalization than …

Prostate cancer has the highest prevalence of any nonskin cancer in the human body, with
similar likelihood of neoplastic foci found within the prostates of men around the world …

In human beings, two forms of GnRH, termed GnRH-I and GnRH-II, encoded by separate
genes have been identified. Although these hormones share comparable cDNA and …

In view of non-specific toxicity of most chemotherapeutic agents against normal cells, the
development of targeted chemotherapy is warranted. Efficient targeting of chemotherapeutic …

Recently, specific binding sites for luteinizing hormone releasing hormone (LHRH) and its
analogues have been demonstrated in biopsy samples of human epithelial ovarian cancer …

Targeted chemotherapy is a modern approach aimed at increasing the efficacy of systemic
chemotherapy and reducing its side effects. The peptide receptors expressed primarily on …

GnRH is one of the paracrine/autocrine regulators of hCG secretion produced by the human
trophoblast during pregnancy. We hypothesized that GnRH may play a role in the …

OBJECTIVE: To evaluate whether an alternative treatment to radical hysterectomy exists for
young women with endometrial adenocarcinoma. DESIGN: A review of the literature (70 …

Endometrial cancer (EC) is one of the most common gynecological malignancies.
Gonadotropin releasing hormone (GnRH) is a decapeptide first described to be secreted by …

Gonadotropin‐releasing hormone (GnRH) has historically been known as a pituitary
hormone; however, in the past few years, interest has been raised in locally produced …